Quoin Pharmaceuticals Ltd DRC (QNRX)

5.29
-8.77(-62.38%)
Pre Market
6.04
+0.75(+14.18%)
- Real-time Data
  • Volume:
    16,371,915
  • Day's Range:
    4.33 - 7.10
  • 52 wk Range:
    3.58 - 444.00
Unusual trading volume

QNRX Overview

Prev. Close
14.06
Day's Range
4.33-7.1
Revenue
-
Open
6.58
52 wk Range
3.58-444
EPS
-28.68
Volume
16,371,915
Market Cap
7.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,176,314
P/E Ratio
-0.184
Beta
1.83
1-Year Change
-97.48%
Shares Outstanding
1,436,069
Next Earnings Date
23 Aug 2022
What is your sentiment on Quoin Pharmaceuticals DRC?
or
Market is currently closed. Voting is open during market hours.

Quoin Pharmaceuticals Ltd DRC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Quoin Pharmaceuticals Ltd DRC Company Profile

Quoin Pharmaceuticals Ltd DRC Company Profile

Employees
4

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targeting rare skin diseases, including epidermolysis bullosa, Netherton Syndrome, and Scleroderma. Quoin Pharmaceuticals, Ltd. was incorporated in 2018 and is based in Ashburn, Virginia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell